.
Report from the Asian News International brought to you by the Hindustan Times.
Washington, April 27 -- Cancer researchers at Ontario Cancer Institute (OCI) have developed a method to convert normal human blood cells into 'human' leukaemia stem cells.
The converted cells, when transplanted into special mice that permit the growth of human cells, can replicate the entire disease process from the very moment it begins.
"Most human leukaemia research involves studying a patient's diseased cells or a cell line grown from those cells. However, since cancer takes many months or years to develop, just studying the cells at the end of the process does not let you know what…
The full-text version of this article will be available soon on HighBeam Business.
No comments:
Post a Comment